Crossmark

Pharmacokinetic Factors to Consider in the Selection of Antiseizure Drugs for Older Patients with Epilepsy

Crossref DOI link: https://doi.org/10.1007/s40266-018-0562-2

Published Online: 2018-07-13

Published Print: 2018-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Anderson, Gail D.

Hakimian, Shahin
License Information

Text and Data Mining valid from 2018-07-13
More Information

Article History

First Online: 13 July 2018

Compliance with Ethical Standards

:

: Gail Anderson has no conflicts of interest directly relevant to the content of this article. Shahin Hakimian has participated in clinical trials involving several antiepileptic drugs, a few of which are discussed in this article, as a local co-primary investigator. He has not received any salary support or contribution for his participation. Shahin Hakimian has also consulted for a pharmaceutical drug benefits company, OptumRx, which has no relation to or influence on the current manuscript.